Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P De Deyn

Showing results (451-460 of 493) with videos related to

Pageof 50
Sort By:
Neurology|November 20, 2015
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohortIlse Gijselinck, Sara Van Mossevelde, Julie van der Zee, et al.
Acta Neurologica Belgica|October 7, 2017
Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical AssociationJan Versijpt, Mark Tant, Ingo Beyer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 20, 2021
Kinetics and 28-day test-retest repeatability and reproducibility of [<sup>11</sup>C]UCB-J PET brain imagingHayel Tuncel, Ronald Boellaard, Emma M Coomans, et al.
Acta Neuropathologica Communications|November 12, 2015
Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brainsJonathan Janssens, Stéphanie Philtjens, Gernot Kleinberger, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Circulation|September 6, 2013
Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studiesChi-un Choe, Dorothee Atzler, Philipp S Wild, et al.
Human Mutation|March 9, 2007
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementiaJulie van der Zee, Isabelle Le Ber, Sebastian Maurer-Stroh, et al.
Neurobiology of Aging|April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder familyEline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
Acta Neuropathologica Communications|October 23, 2022
Plasma proteome profiling identifies changes associated to AD but not to FTDR Babapour Mofrad, M Del Campo, C F W Peeters, et al.
Pageof 50

Showing results (451-460 of 493) with videos related to

Sort By:
Pageof 50
Neurology|November 20, 2015
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohortIlse Gijselinck, Sara Van Mossevelde, Julie van der Zee, et al.
Acta Neurologica Belgica|October 7, 2017
Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical AssociationJan Versijpt, Mark Tant, Ingo Beyer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 20, 2021
Kinetics and 28-day test-retest repeatability and reproducibility of [<sup>11</sup>C]UCB-J PET brain imagingHayel Tuncel, Ronald Boellaard, Emma M Coomans, et al.
Acta Neuropathologica Communications|November 12, 2015
Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brainsJonathan Janssens, Stéphanie Philtjens, Gernot Kleinberger, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Circulation|September 6, 2013
Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studiesChi-un Choe, Dorothee Atzler, Philipp S Wild, et al.
Human Mutation|March 9, 2007
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementiaJulie van der Zee, Isabelle Le Ber, Sebastian Maurer-Stroh, et al.
Neurobiology of Aging|April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder familyEline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
Acta Neuropathologica Communications|October 23, 2022
Plasma proteome profiling identifies changes associated to AD but not to FTDR Babapour Mofrad, M Del Campo, C F W Peeters, et al.
Pageof 50